Due to the characteristic of adiponectin/leptin ratio in obesity in general, there is strong possibility that the ratio would also serve as an excellent marker for pancreatic cancer, similar to IL-6/IL-8 ratio, for tracking inflammation for clinical purposes. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.